Bilateral V-Y advancement gluteal fold flaps following vulvo-vaginal melanoma resection
Abstract
##plugins.themes.bootstrap3.article.details##
vulvar melanoma, perineum reconstruction, gluteal fold flap, melanoma
2. McAninch JW. Management of genital skin loss. Urol Clin North Am 1989; 16(2):387-397.
3. Payne CE, Williams AM, Hart NB. Lotus petal flaps for scrotal reconstruction combined with Integra resurfacing of the penis and anterior abdominal wall following necrotizing fasciitis. J Plast Reconstr Aesthet Surg 2009; 62(3):393-397.
4. Butler CE, Gundesliogu AO, Rodriguez-Bias MA. Outcomes of immediate vertical rectus abdominis myocutanous flap reconstruction for irradiated abdominoperineal defects. J Am Coll Surg 2008; (206):694-703.
5. Kieran I, Nugent N, Riordain MO, Kelly J. Reconstruction of the pelvis and perineum with a free latissimus dorsi myocutaneous flap: a case report. Ann R Coll Surg Engl 2012; 94(8): e254–e256.
6. Salgado CJ,Chim H, Skowronski PP, Oeltjen J, Rodriguez M, Mardini S. Reconstruction of acquired defects of the vagina and perineum. Semin Plast Surg 2011; 25:155–162.
7. Pantelides NM, Davies RJ, Fearnhead NS, Malata CS. The gluteal fold flap: A versatile option for perineal reconstruction following anorectal cancer resection J Plast, Reconstr Aesthet Surg 2013; 66:812-e820.
8. Weinstock MA. Malignant melanoma of the vulva and vagina in the United States: Patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol 1994; 171:1225-1230.
9. Ragnarsson-Olding B, Johansson H, Rutqvist LE, et al: Malignant melanoma of the vulva and vagina. Cancer 1993; 71:1893-1897.
10. Podratz KC, Gaffey TA, Symmonds RE, et al. Melanoma of the vulva: An update. Gynecol Oncol 1983; 16:153-168.
11. Scheistroen M, Trope C, Koern J, et al. Malignant melanoma of the vulva: evaluation of prognostic factors with emphasis on DNA poloidy in 75 patients. Cancer 1995; 75:72-80.
12. Rose PG, Piver MS, Tsukada Y, et al. Conservative therapy for melanoma of the vulva. Am J Obstet Gynecol 1988; 159:520-525.
13. Bradgate MG, Rollason TP, McConkey CC, et al. Malignant melanoma of the vulva: A clinicopathological study of 50 women. Br J Obstet Gynecol 1990; 97:124-133.
14. Tasseron EWK, van der Esch EP, Hart AAM, et al. A clinicopathological study of 30 melanomas of the vulva. Gynecol Oncol 1992; 46:170-175.
15. Phillips GL, Bundy BN, Okagaki T, et al. Malignant melanoma of the vulva treated by radical hemivulvectomy: A prospective study of the Gynecologic Oncology Group. Cancer 1994; 73:2626-2632.
16. Trimble EL. Melanomas of the vulva and vagina. Oncology 1996; 10(7):1017-23; discussion 1024.
17. Davidson T, Kissin M, Westbury G: Vulvo-vaginal melanoma-should radical surgery be abandoned? Br J Obstet Gynecol 1987; 94:473-476.
18. Reid GC, Schmidt RW, Roberts JA, et al. Primary melanoma of the vagina: A clinicopathologic analysis. Obstet Gynecol 1989; 74:190-199.
19. Veronesi U, Cascinelli N. Narrow excision (1 cm margin): A safe procedure for thin cutaneous melanoma. Arch Surg 1991; 126:438-441.
20. Pritchard KI, Quirt IC, Cowan DH, et al. DTIC therapy in metastatic malignant melanoma: A simplified dose schedule. Cancer Treat Rep 1989; 64:1123.
21. Mughal M, Baker RJ, Muneer A, Mosahebi A. Reconstruction of perineal defects. Ann R Coll Surg Engl 2013; 95:539-544.
22. Niranjan NS. Perforator flaps for perineal reconstruction. Semin Plast Surg 2006; 20(2):133-144.
23. Lee PK, Choi MS, Ahn ST, et al. Gluteal fold V-Y advancement flap for vulvar and vaginal reconstruction: A new flap. Plast Reconstr Surg 2006; 118(2):401-406.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.